Brumm Joshua T 4
4 · CRESCENT BIOPHARMA, INC. · Filed Dec 10, 2025
Insider Transaction Report
Form 4
Brumm Joshua T
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-08+345,672→ 345,672 totalExercise: $13.17Exp: 2035-12-08→ Ordinary Shares (345,672 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase shares of the Issuer's ordinary shares and vests in 48 approximately equal monthly installments that commenced on December 8, 2025.